GlassScriptPhysician profile
Lauren Mize
NPI 1598414765
$296.36
in general payments reported to CMS, 2019-2025
13 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.54 · 2024: $75.71 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $66.48 | 2023-2025 | Veozah |
| Abbvie INC. | $35.71 | 2025 | |
| Sage Therapeutics, LLC | $34.71 | 2024-2025 | Zurzuvae |
| Organon LLC | $28.26 | 2024-2025 | Nexplanon |
| Solventum Corporation | $23.54 | 2025 | Prevena |
| Pfizer INC. | $19.23 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $18.26 | 2025 | Zoryve |
| Dexcom, INC. | $16.22 | 2025 | Dexcom G6 Transmitter |
| Shield Therapeutics INC | $15.28 | 2025 | |
| Lilly USA, LLC | $13.79 | 2024 | Zepbound |
| Mayne Pharma Commercial LLC | $11.14 | 2024 | |
| Phathom Pharmaceuticals, INC. | $9.50 | 2025 | Voquezna |
| Evofem Biosciences, INC. | $4.24 | 2025 | Phexxi, Solosec, Phexx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Mize listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.